A single site, open-label phase I trial of NDI 010976 in healthy volunteers.

Trial Profile

A single site, open-label phase I trial of NDI 010976 in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs GS 0976 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Nimbus Therapeutics
  • Most Recent Events

    • 04 Apr 2016 According to a Gilead Sciences media release, the results of this trial will be presented at The International Liver Congress 2016, the annual meeting of the European Association for the Study of the Liver (EASL).
    • 24 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top